PeptideDB

GNX-865

CAS: 1223568-82-8 F: C16H14ClNO3 W: 303.74

GNX-865 is a mitochondrial permeability transition pore (mPTP) inhibitor that protects against ischemia-reperfusion inju
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity GNX-865 is a mitochondrial permeability transition pore (mPTP) inhibitor that protects against ischemia-reperfusion injury in vivo[1].
Name GNX-865
CAS 1223568-82-8
Formula C16H14ClNO3
Molar Mass 303.74
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Reference [1]. Fancelli D, et al. Cinnamic anilides as new mitochondrial permeability transition pore inhibitors endowed with ischemia-reperfusion injury protective effect in vivo. J Med Chem. 2014 Jun 26;57(12):5333-47.

(1R,1'S,3'R/1R,1'R,3'S)-L-054,264

URAT1 inhibitor 7

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.